Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Matteo Capaia"'
Autor:
Carlo Cattrini, Paola Barboro, Alessandra Rubagotti, Linda Zinoli, Elisa Zanardi, Matteo Capaia, Francesco Boccardo
Publikováno v:
Translational Oncology, Vol 13, Iss 7, Pp 100789- (2020)
Periostin (POSTN) is an extracellular matrix protein associated with tumor progression and shorter survival in prostate cancer (PCa). Here, we performed an integrative analysis of POSTN’s role in patients with PCa. Clinical and POSTN data from larg
Externí odkaz:
https://doaj.org/article/7484fe20228e435fa414c30d6a46cfec
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss , Pp 100221- (2020)
Background: Etoposide phosphate (VP-16) is a topoisomerase 2 (TOP2) inhibitor that demonstrated activity in patients with metastatic castration-resistant prostate cancer (mCRPC). We investigated the sensitivity of prostate cancer (PCa) cells (LNCaP,
Externí odkaz:
https://doaj.org/article/973b54e571fa4b788ac29e6a5f9a2379
Autor:
Nicoletta Ferrari, Ilaria Granata, Matteo Capaia, Marina Piccirillo, Mario Rosario Guarracino, Roberta Venè, Antonella Brizzolara, Andrea Petretto, Elvira Inglese, Martina Morini, Simonetta Astigiano, Adriana Agnese Amaro, Francesco Boccardo, Cecilia Balbi, Paola Barboro
Publikováno v:
Cell Communication and Signaling, Vol 15, Iss 1, Pp 1-14 (2017)
Abstract Background Prostate cancer (PCa), the second most common cancer affecting men worldwide, shows a broad spectrum of biological and clinical behaviour representing the epiphenomenon of an extreme heterogeneity. Androgen deprivation therapy is
Externí odkaz:
https://doaj.org/article/152055dcfe94475ebcb72884d12d5188
Autor:
Matteo Capaia, Ilaria Granata, Mario Guarracino, Andrea Petretto, Elvira Inglese, Carlo Cattrini, Nicoletta Ferrari, Francesco Boccardo, Paola Barboro
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 7, p 1920 (2018)
The major challenge in castration-resistant prostate cancer (CRPC) remains the ability to predict the clinical responses to improve patient selection for appropriate treatments. The finding that androgen deprivation therapy (ADT) induces alterations
Externí odkaz:
https://doaj.org/article/54e77eb013f34dbb8f6504df5349be18
Autor:
Loris De Cecco, Matteo Capaia, Simona Zupo, Giovanna Cutrona, Serena Matis, Antonella Brizzolara, Anna Maria Orengo, Michela Croce, Edoardo Marchesi, Manlio Ferrarini, Silvana Canevari, Silvano Ferrini
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0134706 (2015)
Several factors support CLL cell survival in the microenvironment. Under different experimental conditions, IL21 can either induce apoptosis or promote CLL cell survival. To investigate mechanisms involved in the effects of IL21, we studied the abili
Externí odkaz:
https://doaj.org/article/978df493983b486d819af857600495b2
Autor:
Roberta Venè, Paola Barboro, Simonetta Astigiano, Delfina Costa, Matteo Capaia, Francesca Tosetti, Roberto Benelli, Nicoletta Ferrari, Alessandro Poggi
Publikováno v:
Carcinogenesis. 41:1246-1252
Castration-resistant prostate cancer (CRPC) is an incurable stage of the disease. A multivariate principal component analysis on CRPC in vitro models identified aspartyl (asparaginyl) β hydrolase (ASPH) as the most relevant molecule associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e1f7de79a0e35bcfe1a2f7bfbd1ed4
https://doi.org/10.1093/carcin/bgaa053
https://doi.org/10.1093/carcin/bgaa053
Publikováno v:
Cancer Treatment and Research Communications, Vol 25, Iss, Pp 100221-(2020)
Background. Etoposide phosphate (VP-16) is a topoisomerase 2 (TOP2) inhibitor that demonstrated limited activity in patients with metastatic castration-resistant prostate cancer (mCRPC). In our study, we investigated the sensitivity of prostate cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74a4ba27eb8523a49aa3bb8d633c1e3d
https://doi.org/10.21203/rs.3.rs-42290/v1
https://doi.org/10.21203/rs.3.rs-42290/v1
Autor:
Elisa Zanardi, Paola Barboro, Francesco Boccardo, Carlo Cattrini, Matteo Capaia, Linda Zinoli, Alessandra Rubagotti
Publikováno v:
Translational Oncology, Vol 13, Iss 7, Pp 100789-(2020)
Translational Oncology
Translational Oncology
Periostin (POSTN) is an extracellular matrix protein associated with tumor progression and shorter survival in prostate cancer (PCa). Here, we performed an integrative analysis of POSTN's role in patients with PCa. Clinical and POSTN data from large-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac7820c189921fbefd04c8dca47b44f9
http://www.sciencedirect.com/science/article/pii/S1936523320302953
http://www.sciencedirect.com/science/article/pii/S1936523320302953
Autor:
Matteo Capaia, Ottavia Barbieri, Paola Barboro, Alessandro Poggi, Nicoletta Ferrari, Roberto Benelli, Delfina Costa, Simonetta Astigiano
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 23
Volume 20
Issue 23
Background: Prostate cancer (PCa) is a significant health concern throughout the world. Standard therapy for advanced disease consists of anti-androgens, however, almost all prostate tumors become castration resistant (CRPC). Progression from androge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab5e8e8e69d1eab209660c3810c3296e
https://pubmed.ncbi.nlm.nih.gov/31816863
https://pubmed.ncbi.nlm.nih.gov/31816863
Autor:
Elisa Zanardi, Matteo Capaia, Francesco Boccardo, Carlo Cattrini, Luigi Cerbone, Alessandra Rubagotti, Linda Zinoli, Paola Barboro
Publikováno v:
Cancers, Vol 11, Iss 9, p 1365 (2019)
Cancers
Volume 11
Issue 9
Cancers
Volume 11
Issue 9
Background: Circulating tumor cells (CTC), androgen receptor full-length (AR-FL), and androgen receptor splice variant 7 (AR-V7) are prognostic in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). AR-V7 seems to predict res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c90048d3b71ec4ea5613863e9a321f1
http://hdl.handle.net/11567/972688
http://hdl.handle.net/11567/972688